Skip to content
Head to head

Intuitive Surgical vs Becton Dickinson & Co

Side-by-side on the measures that matter, with a plain-English read. Full detail: ISRG · BDX

Updated moments ago

1-year performance, rebased to 100

ISRG -27.0%BDX +45.3%
Intuitive Surgical edges it on the scoreable measures. Intuitive Surgical trades cheapest on trailing earnings; Intuitive Surgical earns the most per share.
ISRGBDX
Snapshot
Sector--Medical Instruments & Supplies
Last price399.05212.78
Change today-2.01%+0.05%
1-year return-27.7%+46.3%
Market cap$138.33B$57.96B
52-week range328.57 – 603.88139.29 – 220.36
Valuation
P/E (TTM)48.2552.02
P/E percentile, own 5-yr range16th86th
P/B8.652.35
Dividend yield0.00%1.97%
Profitability & growth
EPS (TTM)7.874.09
Net profit (TTM)$2.73B$1.11B
Revenue (TTM)$11.58B$20.22B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+21.7%-36.5%
Gross margin67.2%47.4%
Operating margin32.3%15.7%
Net margin25.5%5.9%
Free cash flow (TTM)$3.60B$2.69B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership86.7%97.3%
Insider activity (12mo)17 buy / 33 sell25 buy / 20 sell
Short interest (% of float)2.0%3.0%
Analyst consensus100% buy (18)56% buy / 33% hold / 11% sell (9)
Analyst price target$516 (+29%)$230 (+8%)
StockVane view
StockVane Quant RatingE (15)C (85)
Company
Employees17,02172,000
Founded19951906

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.